Evidence map›Paper›PMID 18306376›Full record

ArticleLiver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society2008

Relative contribution of direct and indirect allorecognition in developing tolerance after liver transplantation.

Hideyoshi Toyokawa, Atsunori Nakao, Robert J Bailey, Michael A Nalesnik, Takashi Kaizu, Jerome L Lemoine, Atsushi Ikeda, Koji Tomiyama, Glenn D Papworth, Leaf Huang and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 2 countries.

Hideyoshi ToyokawaThomas E. Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA 15261, USA.
Atsunori Nakao
Robert J Bailey
Michael A Nalesnik
Takashi Kaizu
Jerome L Lemoine
Atsushi Ikeda
Koji Tomiyama
Glenn D Papworth
Leaf Huang
Anthony J Demetris
Thomas E Starzl
Noriko Murase
University of Pittsburgh Medical Center · US

Funding

UNIVERSITY OF PITTSBURGH CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTE: BPCAUL1RR024153 · NCRR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2006 to 2011
$73.9M
University of Pittsburgh Clinical and Translational Science InstituteUL1TR000005 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2012 to 2015
$50.8M
INFLAMMATORY TOXICITY IN NON-VIRAL GENE THERAPYR01AI048851 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HUANG, LEAF · 2001 to 2005
$1.1M
ORTHOTOPIC LIVER TRANSPLANTATIONR01DK029961 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI STARZL, THOMAS E · 1986 to 2001
$876k
Safe and Efficacious Non-viral Vectors for Gene TherapyR56AI048851 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI HUANG, LEAF · 2007 to 2007
$329k
NCATS NIH HHS UL1 TR000005NCRR NIH HHS UL1 RR024153NIAID NIH HHS AI048851NIAID NIH HHS AI38899NIDDK NIH HHS R01 DK029961
6 · The paper itself

Abstract

The interaction of donor passenger leukocytes and host leukocytes in recipient secondary lymphoid tissues during the early posttransplantation period is crucial in directing host immune reactions toward allograft rejection or acceptance. Responsible T cell clones could be activated through the direct and indirect pathways of allorecognition. We examined the role of the indirect pathway in liver transplantation (LT) tolerance by depleting host antigen-presenting cells (APC) with phagocytic activity [e.g., cluster domain (CD)68+/CD163+ macrophages, CD11c+ dendritic cells (DC)] using liposome-encapsulating clodronate (LP-CL). After Lewis rat cell or liver graft transplantation, Brown Norway (BN) rat recipients pretreated with LP-CL showed a significantly reduced type 1 helper T cell cytokine up-regulation than control-LP-treated recipients. In the LT model, LP-CL treatment and host APC depletion abrogated hepatic tolerance; Lewis liver grafts in LP-CL-treated-BN recipients developed mild allograft rejection, failed to maintain donor major histocompatibility complex (MHC) class II+ leukocytes, and developed chronic rejection in challenged donor heart allografts, while control-LP-treated BN recipients maintained tolerance status and donor MHC class II+ hepatic leukocytes. Furthermore, in the BN to Lewis LT model, LP-CL recipient treatment abrogated spontaneous hepatic allograft acceptance, and graft survival rate was reduced to 43% from 100% in the control-LP group. In conclusion, the study suggests that host cells with phagocytic activity could play significant roles in developing LT tolerance.

Indexed as

AnimalsAntigen-Presenting CellsClodronic AcidDendritic CellsGraft RejectionGraft SurvivalImmune ToleranceLeukocytesLiposomesLiver TransplantationMacrophagesMalePhagocytosisRatsRats, Inbred BNRats, Inbred LewClodronic AcidLiposomes

Identifiers

PMID18306376
PMCPMC3022430
OpenAlexW2144851189

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.